Subramanian Sanjay
SEC insider (Form 3/4/5 filer). CIK 0001790246. Chief Financial Officer at SCYNEXIS INC (SCYX) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in JERSEY CITY, NJ.
Companies Subramanian Sanjay has filed insider reports for
- SCYNEXIS INC (SCYX): Officer, Chief Financial Officer
- Inozyme Pharma, Inc. (INZY): Officer, SVP, CFO
Subramanian Sanjay
CIK: 0001790246
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Sep 9, 2026SCYX
SCYNEXIS INC
AwardDirectStock Option (Right to Buy)
100K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Tender OfferDirect39.7K shares at avg. $4.00$159K - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectRestricted Stock Units
38.5K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
180K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
135K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
DispositionDirectStock Option (Right to Buy)
145K shares- - Jun 25, 2025INZY
Inozyme Pharma, Inc.
AwardDirect6.8K shares at avg. $0.74$5K - Mar 31, 2025INZY
Inozyme Pharma, Inc.
AwardDirect2.5K shares at avg. $0.77$2K - Mar 11, 2025INZY
Inozyme Pharma, Inc.
AwardDirectStock Option (right to buy)
145K shares- - Mar 11, 2025INZY
Inozyme Pharma, Inc.
AwardDirectRestricted Stock Units
38.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 9, 2026 |  SCYX SCYNEXIS INC | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Jul 1, 2025 |  INZY Inozyme Pharma, Inc. | Tender Offer | 39,701 | $4.00 | $158,804 | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Restricted Stock Units | 38,500 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 180,000 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 135,000 | - | - | Direct |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Disposition Stock Option (Right to Buy) | 145,000 | - | - | Direct |
| Jun 25, 2025 | INZY Inozyme Pharma, Inc. | Award | 6,813 | $0.74 | $5,042 | Direct |
| Mar 31, 2025 | INZY Inozyme Pharma, Inc. | Award | 2,490 | $0.77 | $1,917 | Direct |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | Award Stock Option (right to buy) | 145,000 | - | - | Direct |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | Award Restricted Stock Units | 38,500 | - | - | Direct |
1-10 of 10 transactions